NCT00610402

Brief Summary

Sturge-Weber Syndrome (SWS) is a neurological disorder characterized at birth by seizures and a large port-wine stain birthmark on the forehead and upper eyelid of one side of the face. SWS is also accompanied by an increased pressure within the eye (glaucoma) which can develop very early in life. Glaucoma represents a group of ocular disorders that are characterized by the loss of retinal ganglion cells and their axons, damage to the optic nerve, and gradual loss of visual field. Recently, several studies provided evidence that there is a potential role of the immune system in the pathogenesis of glaucoma. These findings suggest that there might be changes in systemic humoral immunity possibly underlying the optic neuropathy in at least some glaucoma patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
57

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2007

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2007

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2007

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

January 25, 2008

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 8, 2008

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2008

Completed
Last Updated

October 20, 2022

Status Verified

October 1, 2022

Enrollment Period

Same day

First QC Date

January 25, 2008

Last Update Submit

October 19, 2022

Conditions

Study Arms (1)

blood sample tear drop sample

blood sample tear drop sample

Other: blood sample tear drop sample

Interventions

blood sample tear drop sample

blood sample tear drop sample

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

community sample

You may qualify if:

  • Male and female volunteers with SWS of all ages

You may not qualify if:

  • Volunteers without SWS

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beckman Laser Institute Medical clinic

Irvine, California, 92612, United States

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

blood sample tear drop sample

MeSH Terms

Conditions

Brain Stem Infarctions

Condition Hierarchy (Ancestors)

Brain InfarctionBrain IschemiaCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesStrokeVascular DiseasesCardiovascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Officials

  • John S Nelson, M.D,PhD

    Beckman Laser Institute University of California Irvine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
J.S.Nelson, MD,PhD,Professor of Surgery and Biomedical Engineering

Study Record Dates

First Submitted

January 25, 2008

First Posted

February 8, 2008

Study Start

July 1, 2007

Primary Completion

July 1, 2007

Study Completion

June 1, 2008

Last Updated

October 20, 2022

Record last verified: 2022-10

Locations